Pharmaceuticals Texas’ First and Only Public Charitable Pharmacy Is Going Statewide By Will Maddox | 4 weeks ago In less than three years, St. Vincent de Paul's pharmacy has dispensed more than 32,000 prescriptions to North Texans.
Pharmaceuticals Study: Biosimilars Can Help Address Economic Shortfalls By Plamedie Ifasso | 7 months ago Patients and payors can benefit from more affordable treatment in the wake of the pandemic.
Pharmaceuticals Fears Nachawati, a Local Law Firm, is Taking on the OxyContin Industry and Winning By Will Maddox | 1 month ago The litigation is some of the most complex ever attempted and involves the government, corporations, and other firms.
Pharmaceuticals Dallas-Based Lantern Pharma Is Going Public By Will Maddox | 7 months ago The IPO for the biotechnology company looks to raise $26 million.
Pharmaceuticals McKesson Names Tom Rodgers New Chief Strategy and Business Development Officer By Paige Walters | 7 months ago Rodgers is a McKesson veteran with a big background for the new assignment.
Pharmaceuticals North Texas Receives 79 Cases of Remdesivir to Treat COVID-19 By Will Maddox | 8 months ago Local hospitals will have now have 3,160 doses for critically-ill patients.
Pharmaceuticals Amazon Teams Up With Local Pharmacy Benefits Manager By Will Maddox | 9 months ago Amazon, Pill Pack, and CerpassRx are working to improve medication adherence.
Coronavirus Alto Teams Up With Scripx to Deliver Prescriptions By Will Maddox | 9 months ago As ride share requests dried up, the Dallas company shifted to deliveries of prescriptions and other essentials.
Pharmaceuticals Local Surgeons are Avoiding Opioids After Surgery By Sooha Ahn | 11 months ago 99 percent of the physicians' hip replacement patients have been opioid-free post-operation.
Healthcare Origins of the Opioid Epidemic – I Was There By Will Maddox | 12 months ago Two physicians share their experiences learning the truth about opioids.
Pharmaceuticals McKesson Investors Win $175 Million Opioid Settlement By Will Maddox | 12 months ago Investors say directors didn't maintain proper oversight of opioid shipments.
Pharmaceuticals Plano-Based Reata Pharmaceuticals Raises $500 Million in Stock Offering By Will Maddox | 1 year ago
